Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/1996
11/05/1996US5571840 Method for treating central nervous system ischemia
10/1996
10/30/1996CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM
10/29/1996US5569654 Benzodiazepinones
10/29/1996CA2073873C Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
10/24/1996WO1996032938A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
10/24/1996CA2218391A1 Alpha 1a adrenergic receptor antagonists
10/23/1996EP0738154A1 N-terminus modified analogs of lhrh
10/23/1996EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides
10/23/1996CN1134155A Androstenones
10/22/1996US5567831 Non-steroidal sulfatase inhibitor compounds and their method of use
10/22/1996US5567728 Receptor ligands
10/22/1996US5567712 Naphthyl compounds, intermediates, compositions and methods
10/22/1996CA1338667C Anti-androgen compounds
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/16/1996CN1033033C 19, 11 beta-bridged steroids with progestone anti-activity preparation method
10/15/1996US5565464 Compounds having angiotensine II antagonistic activity
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1032951C Tortoise and soft-shelled turtle composition and its prep.
10/08/1996US5563278 Angiotensin II antagonists
10/08/1996US5563044 Process for the enzymatic preparation of GRF(1-44)NH2
10/08/1996CA2051697C Heterocyclic amines having central nervous system activity
10/03/1996WO1996030050A1 Gene therapy by secretory gland expression
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996CA2216149A1 Gene therapy by secretory gland expression
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/02/1996EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
10/02/1996CN1132205A Novel pharmaceutical product
10/01/1996US5561123 Antitumor agents, anticarcinogenic agent
09/1996
09/26/1996WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
09/25/1996EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
09/25/1996EP0732934A1 Long-acting injection suspensions and a process for their preparation
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996CN1131907A Skin patches and methods for providing testosterone
09/24/1996US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
09/19/1996WO1996028548A1 Receptor activation by gas6
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0731811A1 Chaperonin 10
09/18/1996EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1131154A 8-oxy-5,8-dihydro-6H-dibenzo|a,g¨quinolizine-13-propionic acid derivant, its preparation method and medicinal use thereof
09/17/1996US5556845 11-β substituted-19-nor steroids
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730651A1 Surface loop structural analogues of fibroblast growth factors
09/11/1996EP0730470A1 Improved interferon polymer conjugates
09/04/1996EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996CN1130085A Hyperthyroidism plaster and its preparing method
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552415 Cognition activators
09/03/1996US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
09/03/1996CA2033113C Estrogen-containing gel preparation
08/1996
08/29/1996CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/28/1996EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550150 Using a benzothiophene compound
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/22/1996WO1996025498A2 Mpl ligand analogs
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726901A1 Benzo-fused macrocycles promote release of growth hormone
08/21/1996EP0726771A1 Desferrioxamine oral delivery system
08/21/1996EP0584186B1 Receptor ligands
08/21/1996EP0517820B1 Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity
08/08/1996WO1996023501A1 Methods of decreasing serum calcium levels
08/08/1996CA2211530A1 Methods of decreasing serum calcium levels
08/07/1996EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives
08/07/1996EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
08/07/1996CN1128271A Preparation of stable zinc insulin analog crystals
08/06/1996US5543150 Method of progesterone delivery and affect thereof
08/06/1996CA2026783C Use of il-7 in providing medications for stimulation of platelet production
08/01/1996WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/01/1996CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
07/1996
07/31/1996EP0723780A2 2-Phenyl-3-azoylbenzothiopenes for decreasing serum calcium levels
07/31/1996EP0723453A1 Method of treating reproductive disorders
07/31/1996CN1128031A 15,15-dialkyl-substituted derivatives of estradiol
07/31/1996CN1127753A New imidazolidines substituted by a heterocycle, their preparation process and intermediates, their use as medicaments NAD the pharmaceutical compositions containing them
07/30/1996US5541228 Melatonergic agents
07/24/1996EP0722324A1 Pharmaceutical composition for immunoenhancement therapy
07/24/1996CN1127253A Synthesis of 3-(4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes 08/01/31
07/18/1996WO1996021656A1 Estrogen agonists/antagonists
07/18/1996WO1996021441A1 Methods of inhibiting growth hormone effects
07/18/1996CA2209891A1 Methods of inhibiting growth hormone effects
07/16/1996US5536812 Calcitonin analogue and use thereof
07/16/1996US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses
07/11/1996WO1996020936A1 Novel thiazolidin-4-one derivatives
07/11/1996CA2184174A1 Novel thiazolidin-4-one derivatives